PAR
Nanoparticles
Oral cancer
Oral cancer pain
PAR(2)
Protease-activated receptor 2
Journal
Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316
Informations de publication
Date de publication:
02 Oct 2024
02 Oct 2024
Historique:
received:
26
09
2024
accepted:
01
10
2024
medline:
18
10
2024
pubmed:
18
10
2024
entrez:
17
10
2024
Statut:
aheadofprint
Résumé
Oral cancer is notoriously painful. Activation of protease-activated receptor 2 (PAR
Identifiants
pubmed: 39418848
pii: S0142-9612(24)00408-3
doi: 10.1016/j.biomaterials.2024.122874
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122874Informations de copyright
Copyright © 2024. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Nigel W. Bunnett reports a relationship with Endosomal Therapeutics Inc that includes: equity or stocks. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.